article thumbnail

BioNTech posts €808M loss as company continues to come to grips with seasonal COVID vaccine market

Fierce Pharma

While Pfizer’s German mRNA partner BioNTech has high hopes for its post-COVID future, the company continues to feel the squeeze from the changeover to a seasonal vaccine market.

Marketing 363
article thumbnail

Takeda's Entyvio holds onto IBD market share despite threat from AbbVie's Skyrizi

Fierce Pharma

Even with new entrants edging into the crowded irritable bowel disease (IBD) market and potentially threatening Entyvio’s spot as the market leader, Takeda figures its product still has room to gro | With a new subcutaneous formulation for Entyvio, the Japanese drugmaker isn't worried about new entrants affecting its leading spot in the first-line (..)

Marketing 235
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why DTC isn’t, and is, marketing

World of DTC Marketing

CPG marketers are trying to maintain market share amid price increases and smaller product sizes, leading to a more significant jump in consumerism. But, in pharma marketing, the changes affect every product category. However, DTC marketing is different, much different. So what’s the opportunity for DTC marketers?

Marketing 252
article thumbnail

At request of AstraZeneca, Europe suspends marketing authorization of COVID vaccine Vaxzevria

Fierce Pharma

On Tuesday, the EMA said it had accepted a request from AZ and withdrawn the company’s marketing authorization for its COVID-19 shot Vaxzevria.

Marketing 349
article thumbnail

Marketing Ops: The New Revenue Hero

As data continues to play a starring role in today’s B2B organizations, both marketing and sales operations professionals are poised to solidify their place as critical revenue drivers.

article thumbnail

Amylyx to pull failed ALS drug Relyvrio from market, cut 70% of staffers

Fierce Pharma

Amylyx Pharmaceuticals is keeping a promise by pulling the amyotrophic lateral sclerosis (ALS) therapy Relyvrio off the market after the drug failed in a confirmatory trial. Amylyx is keeping a promise by pulling the amyotrophic lateral sclerosis (ALS) therapy Relyvrio off the market after the drug failed in a confirmatory trial.

Marketing 305
article thumbnail

Orphan drug market to reach $270B by 2028, led by J&J, Vertex and Roche: Evaluate

Fierce Pharma

The orphan drug sector has long been clearing growth in the larger pharmaceutical market with booming sales. | The orphan drug sector has long been clearing growth in the larger pharmaceutical market with booming sales.

Marketing 312
article thumbnail

The Ultimate Marketing Efficiency Checklist

When times are tough and marketers are asked to do more with the same (or less), we have to make tough choices. Here are 7 creative ways marketers can work smarter (not harder) - with the resources you already have! However, you might be able to squeeze more value from the tools and processes you’re already using.

article thumbnail

Best Practices for Marketing Database Cleanse

Finding a vendor to cleanse and optimize your marketing database can be difficult if you don’t know what to look for. ZoomInfo has produced this eBook to help marketing leaders understand best practices around cost and value when it comes to choosing a B2B contact data provider. This buyer’s guide will cover: Buying Considerations.

article thumbnail

ABCs of Data Normalization for B2B Marketers

It’s not a far stretch to suggest that the topic isn’t exactly what gets marketers excited in their day-to-day workflow. However, if lead generation, reporting, and measuring ROI is important to your marketing team, then data normalization matters - a lot. Well, marketers rely on this grouping to reach their goals.

article thumbnail

Marketing-Led Post-COVID-19 Growth Strategies

Any return to normalcy may seem far-off, but sales and marketing are on the front lines of restarting the economy. However, there’s no team better suited to lead that charge than the marketing department. Strategically aligning your systems and teams. Getting consensus on how to define “qualified leads”.

article thumbnail

Your Guide to Using Conversational Marketing to Drive Demand Generation

Enter conversational marketing — the new paradigm to tackling your business deals and converting prospects in minutes. Studies show the return on investment (ROI) of conversational marketing helps your marketing team drive revenue.

article thumbnail

Marketing-Led COVID-19 Growth Strategies: 2022 and Beyond

Businesses are tasked with beating pre-pandemic numbers, making marketing more essential than ever before. In this eBook, you’ll discover what it takes to develop and drive a successful marketing-led growth strategy. In this eBook, you’ll discover what it takes to develop and drive a successful marketing-led growth strategy.

article thumbnail

How Intent Data Helps Marketers Convert A-List Accounts

One of the biggest challenges for any B2B marketer is understanding your prospects’ next move — who is most likely to buy and when. Without these insights, marketing campaigns can feel more like guesswork, with high investment and little return. We’re here to tell you there’s a better way.

article thumbnail

The Forrester Wave™: B2B Marketing Data Providers, Q2 2021

In our 24-criterion evaluation of B2B marketing data providers, we identified the 11 most significant vendors — Data Axle, Dun & Bradstreet, Enlyft, Global Database, InsideView, Leadspace, Oracle, SMARTe, Spiceworks Ziff Davis, TechTarget, and ZoomInfo Technologies — and researched, analyzed, and scored them.